Christopher H Gibbons, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Autonomic Nervous System Diseases | 27 | 2023 | 270 | 7.680 |
Why?
|
Diabetic Neuropathies | 15 | 2022 | 410 | 5.380 |
Why?
|
Hypotension, Orthostatic | 19 | 2021 | 258 | 4.700 |
Why?
|
alpha-Synuclein | 14 | 2024 | 773 | 3.530 |
Why?
|
Parkinson Disease | 20 | 2024 | 2893 | 2.940 |
Why?
|
Autonomic Nervous System | 13 | 2023 | 707 | 2.630 |
Why?
|
Skin | 22 | 2024 | 4503 | 2.540 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 10 | 2022 | 52 | 2.410 |
Why?
|
Peripheral Nervous System Diseases | 12 | 2023 | 716 | 2.330 |
Why?
|
Nerve Fibers | 14 | 2024 | 709 | 2.160 |
Why?
|
Multiple System Atrophy | 8 | 2024 | 132 | 2.070 |
Why?
|
Sweating | 5 | 2019 | 155 | 1.750 |
Why?
|
Neuralgia | 6 | 2020 | 621 | 1.720 |
Why?
|
Ganglia, Autonomic | 6 | 2012 | 43 | 1.230 |
Why?
|
Biopsy | 14 | 2024 | 6793 | 1.180 |
Why?
|
Autonomic Pathways | 3 | 2020 | 31 | 1.180 |
Why?
|
Autoimmune Diseases of the Nervous System | 4 | 2011 | 75 | 1.160 |
Why?
|
Primary Dysautonomias | 3 | 2021 | 28 | 1.130 |
Why?
|
Valsalva Maneuver | 7 | 2019 | 99 | 1.080 |
Why?
|
Tilt-Table Test | 9 | 2021 | 80 | 1.070 |
Why?
|
Lewy Body Disease | 5 | 2024 | 254 | 1.050 |
Why?
|
Posture | 7 | 2021 | 957 | 1.040 |
Why?
|
Heart Rate | 12 | 2021 | 4214 | 0.990 |
Why?
|
Syncope | 4 | 2020 | 430 | 0.960 |
Why?
|
Amyloid Neuropathies, Familial | 3 | 2024 | 180 | 0.960 |
Why?
|
Polyneuropathies | 3 | 2020 | 139 | 0.960 |
Why?
|
Erythromelalgia | 2 | 2014 | 15 | 0.920 |
Why?
|
Reflex | 5 | 2019 | 375 | 0.850 |
Why?
|
Blood Pressure | 12 | 2021 | 8543 | 0.850 |
Why?
|
Sensory Receptor Cells | 4 | 2018 | 508 | 0.840 |
Why?
|
Pure Autonomic Failure | 5 | 2024 | 16 | 0.800 |
Why?
|
Sweat Glands | 4 | 2011 | 33 | 0.770 |
Why?
|
Skin Physiological Phenomena | 3 | 2018 | 193 | 0.740 |
Why?
|
Microvessels | 3 | 2020 | 585 | 0.710 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2021 | 111 | 0.710 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2020 | 37 | 0.700 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2022 | 667 | 0.680 |
Why?
|
Peripheral Nerves | 3 | 2020 | 490 | 0.670 |
Why?
|
Iatrogenic Disease | 2 | 2020 | 552 | 0.630 |
Why?
|
Epidermis | 4 | 2015 | 539 | 0.620 |
Why?
|
Gastroparesis | 1 | 2020 | 143 | 0.610 |
Why?
|
Diagnostic Self Evaluation | 1 | 2020 | 228 | 0.600 |
Why?
|
Laser-Doppler Flowmetry | 3 | 2013 | 238 | 0.590 |
Why?
|
Electrochemical Techniques | 1 | 2018 | 94 | 0.590 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2021 | 386 | 0.580 |
Why?
|
Galvanic Skin Response | 2 | 2018 | 359 | 0.570 |
Why?
|
Hypoglycemia | 2 | 2017 | 895 | 0.570 |
Why?
|
Dystonic Disorders | 1 | 2021 | 354 | 0.550 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2017 | 3447 | 0.550 |
Why?
|
Sympathetic Fibers, Postganglionic | 3 | 2019 | 14 | 0.550 |
Why?
|
Baroreflex | 2 | 2018 | 154 | 0.530 |
Why?
|
Hypoglycemic Agents | 3 | 2020 | 3109 | 0.510 |
Why?
|
Central Nervous System Diseases | 1 | 2020 | 520 | 0.500 |
Why?
|
Diabetic Angiopathies | 2 | 2017 | 806 | 0.490 |
Why?
|
Humans | 106 | 2024 | 768166 | 0.470 |
Why?
|
Friends | 1 | 2015 | 149 | 0.470 |
Why?
|
Exercise Therapy | 1 | 2021 | 939 | 0.440 |
Why?
|
Diabetes Complications | 1 | 2020 | 1320 | 0.440 |
Why?
|
Pain Threshold | 2 | 2020 | 607 | 0.440 |
Why?
|
Capsaicin | 2 | 2013 | 235 | 0.430 |
Why?
|
Pain | 5 | 2022 | 5100 | 0.430 |
Why?
|
Sympathetic Nervous System | 2 | 2006 | 521 | 0.420 |
Why?
|
Autopsy | 1 | 2017 | 1011 | 0.420 |
Why?
|
Nerve Degeneration | 2 | 2023 | 749 | 0.410 |
Why?
|
Endocrinology | 3 | 2023 | 443 | 0.410 |
Why?
|
Diabetes Mellitus | 6 | 2023 | 5889 | 0.400 |
Why?
|
Autoantibodies | 5 | 2022 | 2121 | 0.390 |
Why?
|
Glucose Clamp Technique | 1 | 2012 | 263 | 0.390 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2430 | 0.380 |
Why?
|
Neurophysiology | 2 | 2020 | 145 | 0.380 |
Why?
|
Sensory System Agents | 1 | 2010 | 24 | 0.360 |
Why?
|
Spinal Cord | 1 | 2019 | 1811 | 0.350 |
Why?
|
Blood Flow Velocity | 1 | 2013 | 1375 | 0.330 |
Why?
|
Middle Aged | 42 | 2024 | 223492 | 0.330 |
Why?
|
Papillomavirus Vaccines | 3 | 2020 | 497 | 0.320 |
Why?
|
Mycophenolic Acid | 2 | 2009 | 348 | 0.320 |
Why?
|
Phosphorylation | 4 | 2024 | 8317 | 0.310 |
Why?
|
Insulin | 4 | 2017 | 6607 | 0.310 |
Why?
|
Sweat | 1 | 2008 | 57 | 0.310 |
Why?
|
Dizziness | 2 | 2020 | 269 | 0.310 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2008 | 62 | 0.310 |
Why?
|
Receptors, Nicotinic | 2 | 2009 | 494 | 0.300 |
Why?
|
Hyperalgesia | 1 | 2012 | 527 | 0.300 |
Why?
|
Hyperglycemia | 1 | 2017 | 1388 | 0.300 |
Why?
|
Male | 48 | 2024 | 364719 | 0.290 |
Why?
|
Neurologic Examination | 4 | 2019 | 914 | 0.290 |
Why?
|
Plasmapheresis | 1 | 2008 | 206 | 0.280 |
Why?
|
Female | 48 | 2024 | 397192 | 0.270 |
Why?
|
Adult | 34 | 2024 | 223646 | 0.270 |
Why?
|
Electrocardiography | 2 | 2017 | 6412 | 0.270 |
Why?
|
Prednisone | 2 | 2009 | 1567 | 0.270 |
Why?
|
Norepinephrine | 2 | 2005 | 898 | 0.260 |
Why?
|
Droxidopa | 1 | 2005 | 10 | 0.260 |
Why?
|
Pathology | 1 | 2009 | 270 | 0.260 |
Why?
|
Caregivers | 1 | 2018 | 2302 | 0.260 |
Why?
|
Stress, Physiological | 1 | 2012 | 1408 | 0.240 |
Why?
|
Sensation Disorders | 1 | 2006 | 160 | 0.240 |
Why?
|
Quality of Life | 3 | 2022 | 13490 | 0.240 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 12252 | 0.240 |
Why?
|
Autoantigens | 1 | 2009 | 890 | 0.230 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14783 | 0.220 |
Why?
|
Tuberculoma | 1 | 2003 | 13 | 0.220 |
Why?
|
Benzoxazoles | 1 | 2024 | 92 | 0.210 |
Why?
|
Aged | 24 | 2024 | 171504 | 0.210 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2003 | 17 | 0.210 |
Why?
|
Blood Glucose | 2 | 2017 | 6430 | 0.210 |
Why?
|
Hypertension | 3 | 2020 | 8616 | 0.210 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2022 | 109 | 0.200 |
Why?
|
Societies, Scientific | 2 | 2020 | 223 | 0.200 |
Why?
|
Fludrocortisone | 1 | 2021 | 24 | 0.190 |
Why?
|
Wound Healing | 1 | 2013 | 2809 | 0.190 |
Why?
|
Neuromuscular Diseases | 1 | 2004 | 260 | 0.190 |
Why?
|
Antiparkinson Agents | 2 | 2017 | 184 | 0.190 |
Why?
|
Fatigue Syndrome, Chronic | 2 | 2020 | 217 | 0.190 |
Why?
|
Prealbumin | 2 | 2024 | 259 | 0.180 |
Why?
|
Syncope, Vasovagal | 2 | 2011 | 39 | 0.180 |
Why?
|
Receptors, Cholinergic | 3 | 2012 | 244 | 0.180 |
Why?
|
Pupil Disorders | 2 | 2012 | 33 | 0.180 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2020 | 98 | 0.170 |
Why?
|
Single-Blind Method | 1 | 2024 | 1587 | 0.170 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2020 | 169 | 0.170 |
Why?
|
Electrodiagnosis | 1 | 2020 | 149 | 0.170 |
Why?
|
Endovascular Procedures | 1 | 2013 | 2216 | 0.170 |
Why?
|
Analysis of Variance | 4 | 2013 | 6229 | 0.160 |
Why?
|
Disease Progression | 5 | 2024 | 13671 | 0.160 |
Why?
|
Societies, Medical | 5 | 2023 | 3968 | 0.150 |
Why?
|
Immunosuppressive Agents | 2 | 2009 | 4206 | 0.150 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2019 | 122 | 0.150 |
Why?
|
Young Adult | 11 | 2021 | 60066 | 0.150 |
Why?
|
Follow-Up Studies | 5 | 2017 | 39348 | 0.150 |
Why?
|
Systole | 1 | 2020 | 937 | 0.150 |
Why?
|
Physical Examination | 2 | 2014 | 1263 | 0.140 |
Why?
|
Papillomavirus Infections | 2 | 2019 | 1640 | 0.140 |
Why?
|
Amyloid | 1 | 2022 | 854 | 0.140 |
Why?
|
Celiac Disease | 1 | 2005 | 820 | 0.140 |
Why?
|
Dyspnea | 1 | 2005 | 1352 | 0.140 |
Why?
|
Capillaries | 1 | 2020 | 755 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 590 | 0.140 |
Why?
|
Retinal Diseases | 1 | 2023 | 710 | 0.130 |
Why?
|
Hospitals, Special | 1 | 2017 | 90 | 0.130 |
Why?
|
Nervous System Diseases | 2 | 2020 | 1662 | 0.130 |
Why?
|
Paresthesia | 2 | 2008 | 160 | 0.130 |
Why?
|
Supine Position | 1 | 2017 | 208 | 0.130 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20227 | 0.130 |
Why?
|
Aged, 80 and over | 7 | 2024 | 59629 | 0.130 |
Why?
|
Paraffin Embedding | 1 | 2017 | 307 | 0.130 |
Why?
|
Enteric Nervous System | 1 | 2019 | 213 | 0.130 |
Why?
|
Cell Count | 2 | 2010 | 1832 | 0.130 |
Why?
|
Muscle, Smooth | 1 | 2019 | 931 | 0.130 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26379 | 0.120 |
Why?
|
Shy-Drager Syndrome | 2 | 2019 | 9 | 0.120 |
Why?
|
Brain | 3 | 2022 | 27360 | 0.120 |
Why?
|
Reference Standards | 3 | 2023 | 1014 | 0.120 |
Why?
|
Pain Measurement | 3 | 2020 | 3583 | 0.120 |
Why?
|
Headache | 1 | 2003 | 1263 | 0.120 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2020 | 952 | 0.120 |
Why?
|
Double-Blind Method | 2 | 2022 | 12465 | 0.120 |
Why?
|
Conditioning, Operant | 1 | 1996 | 308 | 0.120 |
Why?
|
Prospective Studies | 7 | 2024 | 54926 | 0.120 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15948 | 0.110 |
Why?
|
Standard of Care | 3 | 2023 | 568 | 0.110 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7454 | 0.110 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 1972 | 0.110 |
Why?
|
Peripheral Vascular Diseases | 1 | 2017 | 488 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2019 | 1140 | 0.110 |
Why?
|
Time Factors | 6 | 2016 | 40218 | 0.110 |
Why?
|
Piloerection | 1 | 2012 | 5 | 0.110 |
Why?
|
Reference Values | 3 | 2015 | 4938 | 0.110 |
Why?
|
Clinical Protocols | 1 | 2019 | 1443 | 0.100 |
Why?
|
Microscopy, Fluorescence | 1 | 2020 | 2633 | 0.100 |
Why?
|
Iontophoresis | 2 | 2012 | 74 | 0.100 |
Why?
|
Laryngeal Neoplasms | 1 | 2016 | 514 | 0.100 |
Why?
|
Axons | 2 | 2012 | 1677 | 0.100 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15454 | 0.100 |
Why?
|
Reflex, Pupillary | 1 | 2012 | 62 | 0.100 |
Why?
|
Case-Control Studies | 3 | 2020 | 22291 | 0.100 |
Why?
|
Silicones | 2 | 2012 | 228 | 0.090 |
Why?
|
Cohort Studies | 5 | 2024 | 41754 | 0.090 |
Why?
|
Plasma Exchange | 1 | 2011 | 159 | 0.090 |
Why?
|
Pilot Projects | 2 | 2022 | 8741 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1887 | 0.090 |
Why?
|
Leg | 1 | 2015 | 1088 | 0.090 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 13014 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2029 | 0.090 |
Why?
|
Electrophysiology | 1 | 2013 | 1266 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2021 | 81762 | 0.080 |
Why?
|
Consensus | 1 | 2020 | 3212 | 0.080 |
Why?
|
Ion Channels | 1 | 2014 | 1043 | 0.080 |
Why?
|
Antibodies | 3 | 2012 | 2421 | 0.080 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2011 | 465 | 0.080 |
Why?
|
Wallerian Degeneration | 1 | 2009 | 68 | 0.080 |
Why?
|
Hypohidrosis | 1 | 2009 | 29 | 0.080 |
Why?
|
Reward | 1 | 1996 | 981 | 0.080 |
Why?
|
Sensation | 1 | 2010 | 336 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1095 | 0.080 |
Why?
|
Lower Extremity | 1 | 2017 | 1216 | 0.080 |
Why?
|
Administration, Topical | 1 | 2010 | 703 | 0.080 |
Why?
|
Intestines | 1 | 1997 | 1909 | 0.080 |
Why?
|
Hyperhidrosis | 1 | 2008 | 34 | 0.080 |
Why?
|
Cytological Techniques | 1 | 2010 | 217 | 0.080 |
Why?
|
Androgens | 1 | 1996 | 1281 | 0.080 |
Why?
|
Animals | 10 | 2022 | 169246 | 0.070 |
Why?
|
Boston | 2 | 2020 | 9374 | 0.070 |
Why?
|
Diabetic Retinopathy | 1 | 2017 | 1300 | 0.070 |
Why?
|
Automation | 1 | 2010 | 589 | 0.070 |
Why?
|
Urination Disorders | 1 | 2009 | 236 | 0.070 |
Why?
|
Sjogren's Syndrome | 1 | 2009 | 240 | 0.070 |
Why?
|
Vasodilation | 1 | 2010 | 967 | 0.070 |
Why?
|
Acetylcholine | 1 | 2008 | 629 | 0.070 |
Why?
|
Vascular Diseases | 1 | 2014 | 1162 | 0.070 |
Why?
|
Cold Temperature | 1 | 2010 | 791 | 0.060 |
Why?
|
Forearm | 1 | 2008 | 427 | 0.060 |
Why?
|
Adrenergic Agonists | 1 | 2005 | 57 | 0.060 |
Why?
|
Attention | 2 | 2016 | 2424 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6211 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2024 | 65371 | 0.060 |
Why?
|
Gliadin | 1 | 2005 | 80 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8542 | 0.060 |
Why?
|
Fatigue | 1 | 2012 | 1557 | 0.060 |
Why?
|
Adolescent | 4 | 2014 | 89169 | 0.060 |
Why?
|
Skin Temperature | 1 | 2004 | 96 | 0.060 |
Why?
|
Analgesics | 1 | 2011 | 1071 | 0.060 |
Why?
|
Models, Neurological | 1 | 2012 | 1776 | 0.060 |
Why?
|
Reaction Time | 2 | 2012 | 2101 | 0.060 |
Why?
|
Constipation | 1 | 2009 | 570 | 0.060 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2010 | 1124 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2011 | 1892 | 0.050 |
Why?
|
Sensory Thresholds | 1 | 2004 | 377 | 0.050 |
Why?
|
Neuropsychological Tests | 2 | 2016 | 7140 | 0.050 |
Why?
|
Adrenergic Agents | 1 | 2023 | 72 | 0.050 |
Why?
|
Clinical Laboratory Techniques | 1 | 2008 | 747 | 0.050 |
Why?
|
Tachycardia, Sinus | 1 | 2022 | 43 | 0.050 |
Why?
|
Body Temperature Regulation | 1 | 2004 | 292 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2016 | 3980 | 0.050 |
Why?
|
Registries | 1 | 2019 | 8375 | 0.050 |
Why?
|
Blood Pressure Determination | 1 | 2006 | 646 | 0.050 |
Why?
|
Risk | 1 | 2014 | 9613 | 0.050 |
Why?
|
Nausea | 1 | 2005 | 682 | 0.050 |
Why?
|
Functional Laterality | 2 | 2012 | 2264 | 0.050 |
Why?
|
Pyridostigmine Bromide | 1 | 2021 | 32 | 0.050 |
Why?
|
Domperidone | 1 | 2021 | 24 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2005 | 992 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12840 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14729 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4058 | 0.040 |
Why?
|
Receptors, GABA | 1 | 2022 | 312 | 0.040 |
Why?
|
HIV Infections | 2 | 2016 | 17569 | 0.040 |
Why?
|
Dysautonomia, Familial | 1 | 2021 | 94 | 0.040 |
Why?
|
Age Factors | 1 | 2017 | 18412 | 0.040 |
Why?
|
Blood Vessels | 1 | 2005 | 1110 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2015 | 2474 | 0.040 |
Why?
|
Risk Factors | 2 | 2017 | 74944 | 0.040 |
Why?
|
Prevalence | 2 | 2006 | 15869 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2709 | 0.040 |
Why?
|
Peritoneal Cavity | 1 | 1997 | 135 | 0.040 |
Why?
|
Blood Volume | 1 | 2018 | 545 | 0.030 |
Why?
|
Cardiovascular System | 1 | 2004 | 841 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11095 | 0.030 |
Why?
|
Linear Models | 1 | 2006 | 5884 | 0.030 |
Why?
|
Vasoconstriction | 1 | 2018 | 592 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2007 | 4568 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2007 | 2257 | 0.030 |
Why?
|
Amphetamine | 1 | 1996 | 222 | 0.030 |
Why?
|
Immunity, Mucosal | 1 | 1997 | 498 | 0.030 |
Why?
|
Rabbits | 2 | 2011 | 4772 | 0.030 |
Why?
|
Neurology | 1 | 2020 | 786 | 0.030 |
Why?
|
Nitroprusside | 1 | 2012 | 272 | 0.030 |
Why?
|
Mice, SCID | 1 | 1997 | 2627 | 0.030 |
Why?
|
Phenylephrine | 1 | 2012 | 292 | 0.020 |
Why?
|
Equidae | 1 | 2011 | 10 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2862 | 0.020 |
Why?
|
Phenotype | 1 | 2009 | 16726 | 0.020 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2011 | 179 | 0.020 |
Why?
|
H-Reflex | 1 | 2010 | 25 | 0.020 |
Why?
|
Streptozocin | 1 | 2010 | 190 | 0.020 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2011 | 367 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3347 | 0.020 |
Why?
|
Lidocaine | 1 | 2012 | 546 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 1997 | 2393 | 0.020 |
Why?
|
Vasoconstrictor Agents | 1 | 2012 | 656 | 0.020 |
Why?
|
Cross Reactions | 1 | 2011 | 828 | 0.020 |
Why?
|
Neural Conduction | 1 | 2010 | 443 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2337 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2012 | 990 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2011 | 328 | 0.020 |
Why?
|
Executive Function | 1 | 2016 | 1401 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 30010 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2012 | 1741 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2019 | 3841 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2013 | 2357 | 0.020 |
Why?
|
Rats | 2 | 2010 | 23760 | 0.020 |
Why?
|
Memory | 1 | 2016 | 2208 | 0.020 |
Why?
|
Respiration | 1 | 2013 | 1665 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1997 | 3044 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 6029 | 0.020 |
Why?
|
Species Specificity | 1 | 2011 | 2415 | 0.020 |
Why?
|
United States | 3 | 2019 | 73039 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2012 | 1005 | 0.020 |
Why?
|
Tyrosine | 1 | 2010 | 1427 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2007 | 927 | 0.010 |
Why?
|
Motor Neurons | 1 | 2010 | 870 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10399 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2007 | 1090 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8054 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6669 | 0.010 |
Why?
|
Models, Biological | 1 | 1997 | 9495 | 0.010 |
Why?
|
Image Enhancement | 1 | 2011 | 2880 | 0.010 |
Why?
|
HIV-1 | 1 | 1997 | 6961 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1997 | 10266 | 0.010 |
Why?
|
Cognition | 1 | 2017 | 7073 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14164 | 0.010 |
Why?
|
Mice | 2 | 2011 | 82029 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2012 | 4978 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30238 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 17140 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18349 | 0.010 |
Why?
|